Nakajima T, Yamamoto S, Cheng M, Yasukawa K, Hirano T, Kishimoto T, Tokunaga T, Honda M
Laboratory of Immunology, AIDS Research Center, National Institute of Health, Tokyo.
Jpn J Cancer Res. 1992 Apr;83(4):373-8. doi: 10.1111/j.1349-7006.1992.tb00117.x.
Soluble interleukin-6 receptor (sIL-6R) was found to be spontaneously released from human myeloma cell line U266 cells into culture supernatant, and was quantitatively measured with a fluorescence sandwich enzyme-linked immunosorbent assay employing antibodies specific to IL-6R. The supernatant IL-6R was generated only from IL-6R-positive cell lines; myeloma cell lines RPMI8226 and PRMI1788, and myelomonocytic cell lines U937, THP-1, and HL-60. In contrast, it was not released from the IL-6R-negative cells; T cell line Molt-4 and Burkitt lymphoma cell line Raji. SDS-PAGE analysis of the soluble IL-6R from U266 cells suggested a molecular weight of approximately 50-55 kDa, 25-30 kDa smaller than the mature cell surface receptor. These results suggest that the generation of soluble IL-6R may be a maker of myeloma cells and myelomonocytic cells.
可溶性白细胞介素-6受体(sIL-6R)被发现可从人骨髓瘤细胞系U266细胞自发释放到培养上清液中,并使用针对IL-6R的特异性抗体通过荧光夹心酶联免疫吸附测定法定量测定。上清液中的IL-6R仅由IL-6R阳性细胞系产生;骨髓瘤细胞系RPMI8226和PRMI1788,以及骨髓单核细胞系U937、THP-1和HL-60。相比之下,它不会从IL-6R阴性细胞中释放;T细胞系Molt-4和伯基特淋巴瘤细胞系Raji。对U266细胞可溶性IL-6R的SDS-PAGE分析表明,其分子量约为50-55 kDa,比成熟细胞表面受体小25-30 kDa。这些结果表明,可溶性IL-6R的产生可能是骨髓瘤细胞和骨髓单核细胞的一个标志物。